2018
DOI: 10.1371/journal.pntd.0006809
|View full text |Cite
|
Sign up to set email alerts
|

The economic value of identifying and treating Chagas disease patients earlier and the impact on Trypanosoma cruzi transmission

Abstract: BackgroundThe World Health Organization’s 2020 Goals for Chagas disease include access to antiparasitic treatment and care of all infected/ill patients. Policy makers need to know the economic value of identifying and treating patients earlier. However, the economic value of earlier treatment to cure and prevent the Chagas’ spread remains unknown.MethodsWe expanded our existing Chagas disease transmission model to include identification and treatment of Chagas disease patients. We linked this to a clinical and… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
27
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 34 publications
(27 citation statements)
references
References 68 publications
(50 reference statements)
0
27
0
Order By: Relevance
“…Antiparasitic treatment of chronic CD with BZN can slow the progression of the disease and prevent complications, however, this is associated with a high incidence of adverse events, especially in adults, and the benefits are uncertain for particular groups [15,[36][37][38]. As the reduction in parasitic burden and the clinical, social, and economic benefits outweigh the negative aspects of antiparasitic treatment of CD in the chronic phase, PHC is the ideal scenario to guarantee access to early diagnosis and timely treatment of the disease for the population [38,39,40]. However, PHC doctors must know the recommendations for treatment, in addition to knowing how to identify and manage adverse events [15,25,38].…”
Section: Discussionmentioning
confidence: 99%
“…Antiparasitic treatment of chronic CD with BZN can slow the progression of the disease and prevent complications, however, this is associated with a high incidence of adverse events, especially in adults, and the benefits are uncertain for particular groups [15,[36][37][38]. As the reduction in parasitic burden and the clinical, social, and economic benefits outweigh the negative aspects of antiparasitic treatment of CD in the chronic phase, PHC is the ideal scenario to guarantee access to early diagnosis and timely treatment of the disease for the population [38,39,40]. However, PHC doctors must know the recommendations for treatment, in addition to knowing how to identify and manage adverse events [15,25,38].…”
Section: Discussionmentioning
confidence: 99%
“…The estimated economic burden of Chagas disease was calculated between 6,500 and 7,190 million dollars per year [24]. These figures would justify by themselves that governments and policy makers believed that investing on Chagas disease control measures can be a way to improve the health of the population and, at the same time, improve the country's economy [108,109]. For example, a costbenefit study of a congenital Chagas detection program conducted in Bolivia concluded that with an investment of 1.5% of the annual socioeconomic cost of all congenital In addition, institutional coordination will be fundamental at the transnational level in endemic areas as well as in non-endemic countries.…”
Section: Perspectives To Get Chagas Disease Un-orphanedmentioning
confidence: 99%
“…This department has reported outbreaks of oral transmission with the lethality of up to 50% and outbreaks associated with occupational exposure with a significant number of cases (20,21). Currently, Colombia has a program to interrupt the domiciliary vector transmission of T. cruzi by Rhodnius prolixus, which means that oral transmission may increase and, with this, the presence of acute cases (22,23).…”
mentioning
confidence: 99%